List of insiders holdings for CNS Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Cortice Biosciences Inc. 10% Owner | 2024-08-06 17:11:50 | 573,368 0 | 573,368 | Form 4 |
| 2 | Evans Carl Anthony Director | 2024-04-10 21:52:02 | 276,688 0 | 276,688 | Form 4 |
| 3 | Priebe Waldemar 10% Owner | 2023-08-01 17:10:16 | 0 156,807 | 156,807 | Form 4 |
| 4 | Andraczke Andrzej Director | 2023-10-12 18:00:06 | 45,428 0 | 45,428 | Form 4/A |
| 5 | Levin Rami CEO and President | 2026-01-02 17:01:02 | 19,000 0 | 19,000 | Form 4 |
| 6 | Climaco John M Chief Executive Officer | 2025-11-19 17:00:07 | 9,761 0 | 9,761 | Form 4 |
| 7 | O'Loughlin Steve Chief Financial Officer | 2026-03-04 17:01:43 | 9,500 0 | 9,500 | Form 4 |
| 8 | Faulkner Eric Chief Technology Officer | 2026-03-04 17:02:29 | 9,500 0 | 9,500 | Form 4 |
| 9 | Charles Faith L. Director | 2026-05-20 09:03:22 | 7,100 0 | 7,100 | Form 4 |
| 10 | Downs Christopher Chief Financial Officer | 2025-11-19 17:00:02 | 4,881 0 | 4,881 | Form 4 |
| 11 | Gumulka Jerzy Director | 2025-11-19 17:00:02 | 1,517 0 | 1,517 | Form 4 |
| 12 | Mahery Amy Director | 2025-11-19 17:00:06 | 1,517 0 | 1,517 | Form 4 |
| 13 | Cockroft Bettina M. Director | 2025-11-19 17:00:09 | 1,517 0 | 1,517 | Form 4 |
| 14 | Keyes Jeffry R. Director | 2025-11-19 21:07:48 | 1,517 0 | 1,517 | Form 4 |